Researchers "Mend a Broken Heart" With Transformed Scar Tissue
August 23, 2013 1:25 PM
comment(s) - last by
Scar forming cells -- fibroblasts -- are chemically tricked to morph into cardiomyocytes -- heart cells
Researchers are describing that the human body is much more strange and pliable than previously thought -- and that's a good thing. A shining example is the work of
Professor Deepak Srivastava, MD
, a professor at the
Univ. of California - San Francisco
(UCSF) and its affiliate
labs. Dr. Srivastava first discovered that a cocktail of three genes injected into mice could provoke fibroblast cells to become cardiomyocytes -- the cells that pump blood in a beating heart. Now his team has managed to use a slightly more advanced formulation to get human fibroblasts to do the same thing.
I. Cardiofibroblasts Offer a Ready Made Stock of Cells For Heart Repair in Mice
While the holy grail of tissue engineering has long thought to have been to develop
stem cell colonies
trigger them to differentiate
desired cells of any kind
, that has proven tricky in practice. Complex tissue parameters -- pressure, local nutrients, and signals from surrounding cells -- have all been found to influence what target a stem cell decides to become, making what seemed an easy route far harder. So some researchers like Dr. Srivastava have turned in part to look into ways to trick local cell types near
a damaged tissue
into becoming the type of cells in the healthy version of that tissue via gene therapy.
Repairing a (literally) broken heart is one attractive target: every year nearly 600,000 Americans
die of heart disease
. Heart disease is the number one killer in the U.S., according to
the latest statistics
U.S. Centers for Disease Control and Prevention
. It accounts for nearly 600,000 deaths in the U.S. a year, or just under 1 in 4 deaths.
Heart disease kills nearly one in four Americans in the long run. [Image Source: Soracc Photo]
Dr. Srivastava's team considered fibroblasts a particularly attractive target. Recent papers such as
, et al. '04
, et al. '09
reveal that fibroblasts in heart tissue -- cardiofibroblasts -- are found in greater quantities (50-60% of the total cell population) than heart muscle cells (30-40%) -- also known as cadiomyocytes -- despite the cardiomyocytes dominating 75 percent of the cell volume.
In a healthy individual these special helper cells are like the gardeners of the regal estate that is the human heart. They maintain the collagen and other biopolymers found in the extracellular matrix, keep the heart elastic and receptive to electrical signals from the "pacemaker" -- the sinoatrial (SA) node. They also play a key role in a a damaged heart, depositing scar tissue. While this may save the heart from infection and internal bleeding, it also
thickens the heart and prevents it from fully healing
, over time leading to death.
But what if you could trick some of the abundant population of myofibroblasts to become myocardiocytes when heart damage (e.g. a heart attack) occurs, repopulating the damaged region with health tissue, rather than scar tissue.
In 2012 Dr. Srivastava
[abstract] that approach had legs, locating a trio of genes he dubbed GMT -- GATA4, MEF2C, and TBX5. When injected into cardiofibroblasts in mice, GMT triggered them to become cardiomyocytes. But would the approach work with humans?
The fibroblast idea worked on mice in a 2012 study. [Image Source: Science Museum]
That question was put to the test in the UCSF researcher's latest study. The team isolated cardiofibroblasts from three different sources -- fetal heart cells, embryonic stem cells, and neonatal skin cells -- and injected them with GMT. So what happened?
II. Transforming Human Cells Took a Little More Work
, a PhD staff scientist who worked on the human tests describes the frustrating initial results, remarking, "When we injected GMT into each of the three types of human fibroblasts, nothing happened -- they never transformed -- so we went back to the drawing board to look for additional genes that would help initiate the transformation. We narrowed our search to just 16 potential genes, which we then screened alongside GMT, in the hopes that we could find the right combination."
With 16 new genes on tap, they began to test different combinations and slowly eliminate the non-essential genes. They found that at a minimum a five-gene mix -- GMT plus ESRRG and MESP1 -- was necessary. But a seven-gene mix -- GMT, ESRRG, MESP1, MYOCD, and ZFPM2 -- the resulting cells were much better differentiated, being virtually indistinguishable from native cardiomyocytes.
Using a modified cocktail human cardiofibroblasts were tricked into becoming cardiomyocytes.
[Image Source: UCSF/Stem Cell]
The team also tested different cell signalling chemicals to see their effects on the transformation rate. They found that by exposing the cells to TGF-β -- a small intercellular protein that promotes differentiation -- they could speed up the process.
Professor Fu comments, "While almost all the cells in our study exhibited at least a partial transformation, about 20% of them were capable of transmitting electrical signals -- a key feature of beating heart cells. Clearly, there are some yet-to-be-determined barriers preventing a more complete transformation for many of the cells. For example, success rates might be improved by transforming the fibroblasts within living hearts rather than in a dish -- something we also observed during our initial experiments in mice."
Dr. Srivastava enthuses on the success in making the gene therapy work in reprogramming human cells, remarking, "Fibroblasts make up about 50% of all cells in the heart and therefore represent a vast pool of cells that could one day be harnessed and reprogrammed to create new muscle. Our findings here serve as proof of concept that human fibroblasts can be reprogrammed successfully into beating heart cells."
"With more than five million heart attack survivors in the United States, who have hearts that are no longer able to beat at full capacity, our findings -- along with recently published findings from our colleagues -- come at a critical time. We've now laid a solid foundation for developing a way to reverse the damage -- something previously thought impossible -- and changing the way that doctors may treat heart attacks in the future."
The next step is to test the technology
on live pigs. [Image Source: UCSF/Stem Cell]
Professor Fu (the first author) and Dr. Srivastava (the senior author) -- along with eight other undergraduate, graduate, doctoral, and postdoctoral researchers from UCSF and the Gladstone Institutes authored a paper, which
in the peer-reviewed tissue engineering journal
Stem Cell Reports
The next step will be to test the five and seven component blends on the pigs, which are closer on a cellular level to humans than rats. Eventually the researchers hope to reformulate their drugs into "small, drug-like molecules", which would offer safe and efficient delivery of the transformative therapy to cardiac tissue of heart patients.
Stem Cell Reports [Press Release]
This article is over a month old, voting and posting comments is disabled
8/24/2013 3:53:23 PM
my best friend's ex-wife makes $84 hourly on the computer. She has been fired from work for nine months but last month her income was $20948 just working on the computer for a few hours. Here's the site to read more work25.Com
"A politician stumbles over himself... Then they pick it out. They edit it. He runs the clip, and then he makes a funny face, and the whole audience has a Pavlovian response." -- Joe Scarborough on John Stewart over Jim Cramer
Urine Provides Stem Cells Capable of Multiple Therapies
August 1, 2013, 3:15 PM
Human Skin Cells Used to Create Stem Cells, Treat Brain Disease in Mice
February 8, 2013, 1:25 PM
New Method Turns Embryonic/Induced Pluripotent Stem Cells into Cardiac Muscle Cells
May 29, 2012, 5:41 PM
Technique Stimulates Growth of New Blood Vessels of Heart Disease Patients
August 3, 2011, 5:00 PM
Stem Cell Technique Produces Colonies of Blood Cells from Patient's Existing Cells
July 18, 2011, 10:15 AM
Microsoft Co-founder Paul Allen Donates $100M to Fight Raging Ebola Epidemic
October 23, 2014, 6:05 PM
Cool Science Video of the Day: Carnivorous Leech Eats Giant Jungle Worm
October 16, 2014, 6:44 PM
Facebook CEO and Founder, Mark Zuckerberg, Donates $25M to Fight Ebola
October 14, 2014, 5:06 PM
Chagrined Over Leaks, CDC Confirms First U.S. Ebola Diagnosis in Dallas, Texas
September 30, 2014, 5:55 PM
Nail Polish May Soon be Able to Detect Date Rape Drugs
August 26, 2014, 7:57 AM
SpaceX Falcon 9-R Rocket Suffers Malfunction, Self-Destructs During Test Flight
August 23, 2014, 9:36 AM
Most Popular Articles
Amid Theater Boycott Netflix Defiantly Plans New Movies, Plus 3 TV Shows for 2015
October 24, 2014, 7:30 PM
AT&T Defeats Purpose of New Apple SIM, Locks iPad Air 2 SIMs to Its Network
October 24, 2014, 2:17 PM
CVS, Rite Aid Kill Unofficial Apple Pay Support, Burn Google Wallet Users in the Process
October 25, 2014, 5:26 PM
1 Million Credit Card Activated on Apple Pay Within 72 Hours, Walmart CEO Hopes Visa "Suffers"
October 28, 2014, 8:17 AM
Microsoft's Figures Show Desktop Users Flocking to Windows 10 Preview
October 27, 2014, 11:04 AM
Latest Blog Posts
Costco Gives Employees Thanksgiving Off; Wal-Mart Leads "Black Thursday" Charge
Oct 29, 2014, 9:57 PM
"Bear Selfies" Fad Could Turn Deadly, Warn Nevada Wildlife Officials
Oct 28, 2014, 12:00 PM
The Surface Mini That Was Never Released Gets "Hands On" Treatment
Sep 26, 2014, 8:22 AM
ISIS Imposes Ban on Teaching Evolution in Iraq
Sep 17, 2014, 5:22 PM
Space Terrorism is a Looming Threat For the United States
Apr 23, 2014, 7:47 PM
More Blog Posts
Copyright 2014 DailyTech LLC. -
Terms, Conditions & Privacy Information